INcrease Of VAgal TonE in CHF
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 730 participants.
Also called NCT01303718
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 730 participants
- Sponsor
- BioControl Medical
- Registry
-
NCT01303718
-
- Other papers using this trial's data
- Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Belgium, Germany, Israel, Netherlands, Poland, Serbia, United Kingdom
- Registry status
- Terminated
Technical summary
Registry record NCT01303718. Randomized; no masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2015-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- INcrease Of VAgal TonE in CHF
- Acronym
- INOVATE-HF
- Condition
- Left Ventricular Dysfunction
- Condition
- Heart Failure
- Intervention (Device)
- CardioFit® System
- Intervention (Other)
- Standard of Care
- Lead sponsor
- BioControl Medical
Record details
- Record id
cardio:ct-nct01303718- Content hash
055b13ccc594645004f525b46dd2946075888be1d4ef2557661abfa3ca154798